Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06730451

Microbiota Transplantation in Solid Organ Transplantation

Washed Microbiota Transplantation for Postoperative Complications in Solid Organ Transplantation

Status
Recruiting
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
The Second Hospital of Nanjing Medical University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Solid organ transplantation (SOT), an alternative therapy for end-stage diseases, offers increased longevity and better quantity of life. Posttransplant complications such as gastrointestinal symptoms, infection, and graft rejection increase risk with graft failure and death. However, the treatment of abovementioned complications remains unsatisfactory. Gut dysbiosis has been reported in patients with SOT, especially in patients with posttransplant complications. Recipients are more susceptible to gut dysbiosis as long-term use of immunosuppressants, antibiotics and corticosteroids. Restoring gut microbiome may be a promising therapy for posttransplant complications. Washed microbiota transplantation (WMT) is a newly improved methodology of fecal microbiota transplantation based on automatic facilities, washing process and a new delivery routine. In this study, investigators aimed to evaluate the efficacy and safety of WMT for postoperative complications in SOT.

Conditions

Interventions

TypeNameDescription
OTHERWashed Microbiota TransplantationWashed microbiota suspension delivered through mild-gut and lower-gut

Timeline

Start date
2018-01-01
Primary completion
2027-12-31
Completion
2028-12-31
First posted
2024-12-12
Last updated
2024-12-12

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06730451. Inclusion in this directory is not an endorsement.